Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.3845
-0.0099 (-2.51%)
May 14, 2025, 9:48 AM - Market open
Tenaya Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 53.77 | 4.32 | 45.68 | 95.27 | 38.13 | 128.54 | Upgrade
|
| Short-Term Investments | 34.39 | 57.12 | 58.96 | 91.26 | 213.17 | - | Upgrade
|
| Cash & Short-Term Investments | 88.16 | 61.45 | 104.64 | 186.53 | 251.3 | 128.54 | Upgrade
|
| Cash Growth | -27.89% | -41.28% | -43.90% | -25.77% | 95.51% | 382.76% | Upgrade
|
| Other Receivables | - | - | - | 2.25 | - | - | Upgrade
|
| Receivables | - | - | - | 2.25 | - | - | Upgrade
|
| Prepaid Expenses | 5.1 | 5.09 | 5.78 | 4.04 | 4.06 | 1.43 | Upgrade
|
| Other Current Assets | 1.23 | 0.84 | 1.16 | 0.94 | - | - | Upgrade
|
| Total Current Assets | 94.49 | 67.38 | 111.58 | 193.75 | 255.36 | 129.96 | Upgrade
|
| Property, Plant & Equipment | 44.65 | 47.75 | 53.26 | 62.7 | 54.71 | 17.19 | Upgrade
|
| Long-Term Investments | - | - | - | 17.7 | - | - | Upgrade
|
| Other Long-Term Assets | 4.81 | 4.82 | 5.68 | 4.79 | 4.13 | 1.01 | Upgrade
|
| Total Assets | 143.95 | 119.94 | 170.52 | 278.95 | 314.19 | 148.16 | Upgrade
|
| Accounts Payable | 5.06 | 5.16 | 5.63 | 9.58 | 10.72 | 1.02 | Upgrade
|
| Accrued Expenses | 5.52 | 7.47 | 12.03 | 10 | 6.03 | 2.81 | Upgrade
|
| Current Portion of Leases | 2.79 | 2.78 | 4.32 | 4.01 | 1.99 | - | Upgrade
|
| Current Income Taxes Payable | 0.42 | 0.35 | 0.28 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.35 | 0.21 | 0.48 | 0.67 | 3.03 | 1.22 | Upgrade
|
| Total Current Liabilities | 14.15 | 15.98 | 22.73 | 24.25 | 21.77 | 5.04 | Upgrade
|
| Long-Term Leases | 10.12 | 10.83 | 8.11 | 11.09 | 13.71 | - | Upgrade
|
| Other Long-Term Liabilities | 0.29 | 0.28 | 0.25 | 0.23 | 0.18 | 3.68 | Upgrade
|
| Total Liabilities | 24.56 | 27.09 | 31.09 | 35.57 | 35.66 | 8.72 | Upgrade
|
| Common Stock | 0.02 | 0.01 | 0.01 | 0.01 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 660.67 | 607.23 | 542.81 | 522.95 | 434.2 | 1.58 | Upgrade
|
| Retained Earnings | -541.28 | -514.41 | -403.28 | -279.2 | -155.53 | -82.81 | Upgrade
|
| Comprehensive Income & Other | -0.01 | 0.03 | -0.11 | -0.38 | -0.14 | -0.09 | Upgrade
|
| Total Common Equity | 119.4 | 92.85 | 139.42 | 243.38 | 278.53 | -81.32 | Upgrade
|
| Shareholders' Equity | 119.4 | 92.85 | 139.42 | 243.38 | 278.53 | 139.44 | Upgrade
|
| Total Liabilities & Equity | 143.95 | 119.94 | 170.52 | 278.95 | 314.19 | 148.16 | Upgrade
|
| Total Debt | 12.91 | 13.61 | 12.42 | 15.1 | 15.7 | - | Upgrade
|
| Net Cash (Debt) | 75.25 | 47.84 | 92.22 | 189.13 | 235.6 | 128.54 | Upgrade
|
| Net Cash Growth | -32.14% | -48.13% | -51.24% | -19.72% | 83.30% | 382.76% | Upgrade
|
| Net Cash Per Share | 0.82 | 0.56 | 1.25 | 4.22 | 13.29 | 132.23 | Upgrade
|
| Filing Date Shares Outstanding | 162.67 | 87.58 | 78.52 | 66.87 | 41.29 | 1.21 | Upgrade
|
| Total Common Shares Outstanding | 162.66 | 86.54 | 68.33 | 66.86 | 41.29 | 1.21 | Upgrade
|
| Working Capital | 80.33 | 51.4 | 88.85 | 169.51 | 233.58 | 124.92 | Upgrade
|
| Book Value Per Share | 0.73 | 1.07 | 2.04 | 3.64 | 6.75 | -67.18 | Upgrade
|
| Tangible Book Value | 119.4 | 92.85 | 139.42 | 243.38 | 278.53 | -81.32 | Upgrade
|
| Tangible Book Value Per Share | 0.73 | 1.07 | 2.04 | 3.64 | 6.75 | -67.18 | Upgrade
|
| Machinery | 42.09 | 40.07 | 40.28 | 39.98 | 12.64 | 8.97 | Upgrade
|
| Construction In Progress | - | 1.92 | 1.73 | 3.13 | 32.56 | 7.68 | Upgrade
|
| Leasehold Improvements | 26.22 | 26.16 | 25.61 | 23.61 | 7.24 | 7.24 | Upgrade
|
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.